Search filters

List of works by S K Roberts

Australian recommendations for the management of hepatocellular carcinoma: a consensus statement

scientific article published on 13 December 2020

Beneficial response to mycophenolate mofetil by patients with autoimmune hepatitis who have failed standard therapy, is predicted by older age and lower immunoglobulin G and INR levels

scientific article published on 11 April 2019

Comparison of 48-week efficacy of tenofovir vs entecavir for patients with chronic hepatitis B: A network meta-analysis

scientific article published on 07 September 2020

D-livering the message: The importance of vitamin D status in chronic liver disease

scientific article published on May 23, 2012

Editorial: tailoring mycophenolate mofetil rescue therapy for success in autoimmune hepatitis-authors' reply

scientific article published on 01 June 2019

Efficacy and safety of 12 weeks of elbasvir ± grazoprevir ± ribavirin in participants with HCV genotype 2, 4, 5, or 6 infection: the C-SCAPE study

scientific article published on 20 November 2017

Impact of viral hepatitis aetiology on survival outcomes in hepatocellular carcinoma: A large multicentre cohort study.

scientific article published on 17 April 2017

In support of community-based hepatitis C treatment with triage of people at risk of cirrhosis to specialist care

scientific article published on 29 August 2020

Increasing prevalence of primary biliary cholangitis in Victoria, Australia

scientific article published on 06 November 2019

Letter: elderly AIH patients-an important subgroup. Authors' reply

scientific article published on 01 September 2019

Limited impact of IL28B genotype on response rates in telaprevir-treated patients with prior treatment failure

scientific article published on January 12, 2013

Liver transplantation for cryptogenic cirrhosis

scientific article published on 01 July 1997

Nonalcoholic fatty liver disease burden: Australia, 2019-2030

scientific article published on 11 February 2020

Reply to: “Vitamin D status does not predict sustained virologic response or fibrosis stage in chronic hepatitis C genotype 1 infection”

scientific article published on March 14, 2013

Safety profile of standard- vs. high-dose peginterferon alfa-2a plus standard-dose ribavirin in HCV genotype 1/4 patients: pooled analysis from 5 randomized studies

scientific article published on September 4, 2012

Sofosbuvir and velpatasvir with or without voxilaprevir in direct-acting antiviral-naïve chronic hepatitis C: patient-reported outcomes from POLARIS 2 and 3.

scientific article published on 27 November 2017

Sustained virologic response rates with telaprevir by response after 4weeks of lead-in therapy in patients with prior treatment failure

scientific article published on November 23, 2012

Urotensin II Levels Are an Important Marker for the Severity of Portal Hypertension in Children

scientific article published on July 1, 2011